March coverage 2008
1st April, Medical News Today
Research Evaluates
New research published by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme suggests that Uterine Artery Embolisation (UAE) may provide a useful alternative to hysterectomy for the removal of fibroids. This condition can cause heavy painful periods and impair both urinary and reproductive functions. [more] [other links]
13 March, The Earth Times
"Pratchett's donation will help research like ours," say health experts at University of Bradford.
Mr Pratchett was diagnosed with the rae early on-set form of Alzeimer's dissease in December last year. He will announce a pledge of asaround £494,000 at the Alzheimer's Research Trust annual conference. [more]
March issue, Nursing older people
Exorcising their demons
Exercise has been shown to improve mental as well as physical wellbeing. Now, Thelma Agnew reports, its benefits are being tested with the most frail and depressed older people. [more]
March issue, Pharma Times
All along the watchtower
Health technology assessment by bodies like NICE and the SMC can make or break a drug. But who is watching the watchmen? asks Mark Greener [more]
March Newsletter 2008 - Park News - Southampton Science Park
Making a healthy move
The Health Technology Assessment programme (HTA), is making the move to Southampton Science Park. They are undergoing a period of expansion and staff recruitment due to a substantial government investment in health research.
4 March 2008 Pharmafocus
Working with NICE: the ingredients for success
NICE fascinates everyone in the industry, its decision-making on treatments for Alzheimer's disease have been dissected at length by the High Court, and the Commons' Health Select Committee recently issued a report recommending further changes to how it operates. The stakes have been raised further by the suggestion that health technology assessments, possibly by NICE or a successor organisation, might be used to set the prices the NHS pays for drugs.
Despite this turmoil, NICE rulings on medicines remain absolutely vital for pharmaceutical companies trying to increase the uptake of their products. So what are the keys to making a successful submission? [more]
News feeds